Report Content
Chapter 1 Delivery Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Spatial genomics and transcriptomics industry 3600synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Technique trends
2.1.4 Product trends
2.1.5 Application trends
2.1.6 End-user trends
Chapter 3 Spatial Genomics and Transcriptomics Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing R&D investment in genomics and transcriptomics
3.2.1.2 Advances in sequencing technologies
3.2.1.3 Increasing adoption of spatial genomics & transcriptomics in drug discovery
3.2.1.4 Increasing adoption of personalized medicine
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of standardized protocols
3.2.2.2 High cost of technology
3.3 Growth potential analysis
3.3.1 By technique
3.3.2 By product
3.3.3 By application
3.3.4 By end-user
3.4 COVID- 19 impact analysis
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategy dashboard, 2022
4.6 Strategic outlook matrix, 2022
Chapter 5 Spatial Genomics and Transcriptomics Market Size and Forecast, By Technique (USD Million)
5.1 Key trends, by technique
5.2 Spatial transcriptomics
5.2.1 Immunohistochemistry (IHC)
5.2.2 Fluorescent in-situ Hybridization (FISH)
5.2.3 Sequencing
5.2.3.1 Microdissection sequencing
5.2.3.2 In situ sequencing
5.2.3.3 Other sequencing techniques
5.2.4 In-situ capturing
5.2.5 In-silico construction
5.2.6 Microscopy-based RNA imaging techniques
5.2.6.1 Single molecule RNA fluorescence in-situ hybridization (smFISH)
5.2.6.2 Padlock probes/ rolling circle amplification
5.2.6.3 Branched DNA probes
5.2.7 Transcriptome in-vivo analysis (TIVA)
5.3 Spatial genomics analysis
5.3.1 Fluorescence in-situ sequencing
5.3.2 Fluorescence microscopy
5.3.3 Other spatial genomics analysis techniques
Chapter 6 Spatial Genomics and Transcriptomics Market Size and Forecast, By Product (USD Million)
6.1 Key trends, by product
6.2 Consumables
6.3 Instruments
6.3.1 By mode
6.3.1.1 Automated
6.3.1.2 Semi-automated
6.3.1.3 Manual
6.3.2 By Type
6.3.2.1 Sequencing platforms
6.3.2.2 Immunohistochemistry (IHC)
6.3.2.3 Microscopy
6.3.2.4 Flow cytometry
6.3.2.5 Mass spectrometry
6.3.2.6 Other instruments
6.4 Software
6.4.1 Imaging tools
6.4.2 Bioinformatics tools
6.4.3 Storage and management databases
Chapter 7 Spatial Genomics and Transcriptomics Market Size and Forecast, By Application (USD Million)
7.1 Key trends, by application
7.2 Translational research
7.3 Drug discovery & development
Chapter 8 Spatial Genomics and Transcriptomics Market Size and Forecast, By End-user (USD Million)
8.1 Key trends, by end-user
8.2 Pharmaceutical & biotechnology companies
8.3 Contract research organizations
8.4 Academic & research institutes
Chapter 9 Spatial Genomics and Transcriptomics Market Size and Forecast, By Region (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Natera Inc.
10.2 10x Genomics
10.3 Dovetail Genomics
10.4 Illumina, Inc.
10.5 S2 Genomics, Inc.
10.6 NanoString Technologies, Inc.
10.7 Seven Bridges Genomics
10.8 Horizon Discovery Group plc
10.9 CARTANA AB
10.10 READCOOR, INC.
10.11 Bio-Techne Corporation
10.12 Bio-Rad Laboratories, Inc.
10.13 Danahar Corporation
10.14 BioSpyder Technologies Inc.
10.15 Lunaphore Technologies SA
